OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).

OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 7.6 days from acceptance to publication (median values for papers published in this journal in 2020, 1-2 days of FREE language polishing time is also included in this period).

Current Issue: 2021  Archive: 2020 2019 2018 2017

Special Issue

Novel Concepts of Mood and Anxiety in Children

Submission Deadline: March 15, 2021 (Open) Submit Now

Guest Editor

Bettina Bernstein

Clinical Associate Professor of Psychiatry, Department of Psychiatry and Psychiatric Medicine, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA

Website | E-Mail

Research Interests: Complementary and Integrative Medicine, Population Health Interventions to Prevent Anxiety and Mood Disorders in Youth, Prevention of Burnout of Medical Students

About This Topic

Why new effective approaches to the treatment and prevention of mood and anxiety disorders matter. Prevention and amelioration of youth incidence of mood and anxiety disorders is especially salient due to concerns that at this time all persons may be at higher risk due to anxiety generated by the current COVID 19 pandemic.

Data from the National Comorbidity Adolescent Supplement (NCS‐A) study in 2009, have found that as many one-third of all adolescents in the United States (US) have any type of anxiety disorder with approximately one-tenth of the those with anxiety disorders experiencing severe impairment which can interfere with the typical developmental path to adulthood. In 2009, overall 14 percent of adolescents in the US age 12 to 17 years had any type of mood disorder. As of 2017, 3.2 million of adolescents in the US representing 13.3 percent of the today had major depression. Interventions that can reduce mood disorders including major depression may help to reduce suicide which according to CDC data in 2017 is the second leading cause of death among youth in the United States. Complementary and integrative approaches added to or used instead of conventional psychotherapies and psychiatric medications are needed to more broadly disseminate effective strategies for persons who experience problematic side effects or lack of response.

Submissions to cover areas such as complementary and integrative approaches including mindfulness and relaxation-based practices are especially welcome; these practices are generally considered safe for healthy people, however evidence based data on the safety of these practices is needed for persons with a history of abuse or trauma as well as epilepsy or other psychiatric conditions that include psychosis; modifications of practices to improve safety would be extremely helpful for successful clinical usage. Articles should include safety, efficacy and cost effectiveness-data utilizing scientifically sound statistical analyses.


Manuscripts should be submitted online at http://www.lidsen.com/account-login by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. Guidelines for authors and other relevant information for submission of manuscripts are available on the Instructions for Authors page. OBM Neurobiology is an international peer-reviewed Open Access monthly journal published by LIDSEN. Please visit the Instructions for Authors page before submitting a manuscript.